A year's course of benralizumab injections has led to a significant decrease in the frequency of asthma exacerbations -- cutting the rate of exacerbations by a third to a half compared with placebo ...

Please provide your email address to receive an email when new articles are posted on . This patient population had “better outcomes” when receiving benralizumab with or without prednisolone vs.

The efficacy and safety of benralizumab, an interleukin-5 receptor alpha–directed cytolytic monoclonal antibody, for the prevention of exacerbations in patients with moderate to very severe chronic ...